Clinical Trials on OMIM#616708
Total 6 results
-
University Hospital, Clermont-FerrandRecruitingWAC | DeSanto-Shinawi Syndrome | DESSH | WAC SYNDROME | OMIM#616708 | ORPHA:466943France
-
National Human Genome Research Institute (NHGRI)RecruitingMetabolic Disease | Purine-Pyrimidine Metabolism | AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2 | UNG, OMIM *191525, Hyper-IgM Syndrome 5 | NT5C3A<TAB>, OMIM *606224, Anemia, Hemolytic, Due to UMPH1 Deficiency | UMPS, OMIM *613891, Orotic Aciduria | DHODH, OMIM *126064,... and other conditionsUnited States
-
Pitzer CollegeRecruitingOMI, OMI+, Control GroupUnited States
-
Xuanwu Hospital, BeijingRecruitingHydrocephalus | Idiopathic Normal Pressure Hydrocephalus | CSF | Glympathic System | OmicChina
-
National Defense Medical Center, TaiwanNot yet recruitingElectrocardiogram | Cost-effectiveness Analysis | Artificial Intelligence (AI) | OMI - Occlusion Myocardial InfarctionTaiwan
-
Helsinki University Central HospitalActive, not recruitingto Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm